Drugmakers Now ‘Masters’ At Rolling Out Their Own Generics To Stifle Competition
(By Jay Hancock and Sydney Lupkin for Kaiser Health News) When PDL BioPharma’s $40 million blood-pressure medicine faced the threat
Read More(By Jay Hancock and Sydney Lupkin for Kaiser Health News) When PDL BioPharma’s $40 million blood-pressure medicine faced the threat
Read MoreThe affordability of prescription drugs is a pressing concern for many Americans, with broad agreement across the political spectrum that
Read MoreA new bill in Congress aims to give older Americans a tax break for setting aside money for medical expenses.
Read More(By Kate Sheridan for STAT) Health economists walk a precarious tightrope: Their analyses are quantitative and, presumably, emotion-free. But health
Read More(By Shefali Luthra for Kaiser Health News) Shannon Wood Rothenberg walked into her annual physical feeling fine. But more than
Read More(By Barclay E. Berdan, Scott Reiner, and Terry Shaw for STAT) Drug shortages are a major challenge for hospitals. Today, 121
Read More(By Phil Galewitz for Kaiser Health News) A year after calling proposals allowing Americans to import cheaper drugs from Canada
Read More(By Dan Weissmann for Kaiser Health News) When I visited Dr. James Gingerich, he launched into some of the nerdiest
Read MoreAccording to the California attorney general’s office, two pharmaceutical companies will pay the state of California a total of nearly
Read MoreThe Trump administration is proposing a rule that would require hospitals to publish the prices that are negotiated with insurers
Read More